Key facts
- Sonogen’s last known valuation is $6.1M (Dec 2024).
- It has raised $1.4M.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, TEDCO, Ecphora Capital, Jefferson Accelerator Zone — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Sonogen
- ·The full record, as it builds
Funding rounds
No funding rounds for Sonogen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sonogen
Developer of an ultrasonic bone fracture healing technology designed for accelerating bone repair and reducing healing time. The company's technology utilizes a multi-modal ultrasonic stimulation approach validated in animal trials, featuring safe and effective delivery of low-intensity pulsed ultrasound to stimulate bone growth, enabling the medical practitioners to shorten treatment times and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Employees
- 6
- Website
- sonogenmed.com/
- Ownership
- Privately Held (backing)
Sonogen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sonogen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sonogen in its N-PORT filings yet. We sweep new filings monthly.